REGULUS THERAPEUTICS INC.

Profile

Company Names

REGULUS THERAPEUTICS INC.

Addresses

4224 CAMPUS POINT COURT, SUITE 210, SAN DIEGO, CA 92121

10628 SCIENCE CENTER DRIVE, SUITE 225, SAN DIEGO, CA 92121

10628 SCIENCE CENTER DRIVE, SUITE 100, SAN DIEGO, CA 92121

3545 JOHN HOPKINS COURT, SUITE 210, SAN DIEGO, CA 92121

3545 JOHN HOPKINS COURT, SAN DIEGO, CA 92121

Phone Numbers

858-202-6300
888-734-8587

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2009

State Incorporated:

DELAWARE

Total Amount Raised:

$170,544,913.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2021-11-30 
$34,624,999.00 
$34,624,999.00 
$0.00 
Equity 
8
2020-12-04 
$19,383,037.00 
$34,537,555.00 
$15,154,518.00 
Equity 
7
2019-05-07 
$16,736,889.00 
$79,343,959.00 
$62,607,070.00 
Equity 
6
2014-02-04 
$9,999,992.00 
$9,999,992.00 
$0.00 
Equity 
5
2012-10-10 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
4
2012-08-15 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
3
2010-10-27 
$9,999,996.00 
$9,999,996.00 
$0.00 
Equity 
2
2009-03-03 
$20,000,000.00 
$20,000,000.00 
$0.00 
Equity 
1
2009-01-02 
$29,800,000.00 
$29,800,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPHER 
 
AKER 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.
DAVID 
 
BALTIMORE 
DIRECTOR
IMMUNE DESIGN CORP.   |  REGULUS THERAPEUTICS INC.   |  AMGEN INC   |  NANOMEDIX INC.
GRANTLAND 
 
BRYCE 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.
CRIS 
 
CALSADA 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.
BRUCE 
L.A. 
CARTER 
DIRECTOR
XENCOR INC   |  REGULUS THERAPEUTICS INC.   |  BIOTHERA HOLDING CORP.   |  METHEOR THERAPEUTICS CORP   |  NAVIGATING CANCER, INC.
DANIEL 
R. 
CHEVALLARD 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.
KATHRYN 
J. 
COLLIER 
DIRECTOR
REGULUS THERAPEUTICS INC.
KATHRYN 
L. 
COLLIER 
DIRECTOR
REGULUS THERAPEUTICS INC.
STANLEY 
 
CROOKE 
DIRECTOR
REGULUS THERAPEUTICS INC.
DENIS 
 
DRYGIN 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.
MARK 
G. 
FOLETTA 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  VIACYTE INC.
NEIL 
 
GIBSON 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.   |  SHATTUCK LABS, INC.   |  INSTIL BIO, INC.   |  CAUSEWAY THERAPEUTICS LTD
BARRY 
E. 
GREENE 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  KARYOPHARM THERAPEUTICS INC.
JOSEPH 
 
HAGAN 
EXECUTIVE OFFICER, DIRECTOR
WEALTHCOLONY SPV I, L.P.   |  ZOSANO PHARMA CORP   |  OREXIGEN THERAPEUTICS, INC.   |  WEALTHCOLONY SPV II, L.P.   |  REGULUS THERAPEUTICS INC.   |  AF HOLDCO, LLC
JOSEPH 
P. 
HAGAN 
EXECUTIVE OFFICER, DIRECTOR
ZOSANO PHARMA CORP   |  REGULUS THERAPEUTICS INC.
ALICE 
S. 
HUANG 
DIRECTOR
REGULUS THERAPEUTICS INC.
JOHN 
 
MARAGANORE 
DIRECTOR
TALIGEN THERAPEUTICS INC   |  REGULUS THERAPEUTICS INC.   |  AGIOS PHARMACEUTICALS INC   |  ANDROS MEDICINES INC.
GARRY 
 
MENZEL 
EXECUTIVE OFFICER
REGULUS THERAPEUTICS INC.   |  PRONUTRIA BIOSCIENCES, INC.   |  BLACK DIAMOND THERAPEUTICS, INC.
JAKE 
R. 
NUNN 
DIRECTOR
HYPERION THERAPEUTICS INC   |  DERMIRA, INC.   |  TRIVASCULAR TECHNOLOGIES, INC.   |  REGULUS THERAPEUTICS INC.
STELIOS 
 
PAPADOPOULOS 
DIRECTOR
EXELIXIS INC   |  BG MEDICINE, INC.   |  SEMBA BIOSCIENCES INC   |  MACINTOSH LLC   |  REGULUS THERAPEUTICS INC.   |  EPIKAST INC.   |  GRAVITON BIOSCIENCE CORP
B. 
LYNNE 
PARSHALL 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  AKCEA THERAPEUTICS, INC.
WILLIAM 
H. 
RASTETTER 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  CERULEAN PHARMA INC.   |  DARE BIOSCIENCE, INC.
HUGH 
 
ROSEN 
DIRECTOR
REGULUS THERAPEUTICS INC.
SIMOS 
 
SIMEONIDIS 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  ALLY BRIDGE MEDALPHA INTERNATIONAL FUND LTD
DOUGLAS 
E. 
WILLIAMS 
DIRECTOR
ARRAY BIOPHARMA INC   |  AEROVANCE INC   |  REGULUS THERAPEUTICS INC.   |  IRONWOOD PHARMACEUTICALS INC   |  OVID THERAPEUTICS INC.
PASCALE 
 
WITZ 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  PERKINELMER INC
KLEANTHIS 
 
XANTHOPOULOS 
EXECUTIVE OFFICER, DIRECTOR
REGULUS THERAPEUTICS INC.   |  SENTE INC   |  ZP HOLDINGS INC   |  ZOSANO, INC.   |  ZOSANO PHARMA CORP   |  BIONIZ THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-11-30 
2020-12-17
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2020-12-04 
2019-05-14
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-05-07 
2014-02-06
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2014-02-04 
2012-10-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2012-10-10 
2012-10-23
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2012-08-15 
2010-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-10-27 
2010-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-01-02 
2010-11-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-03-03 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
H. C. WAINWRIGHT + CO., LLC
375
NONE
NONE
SVB LEERINK LLC
39011
NONE
NONE
H.C. WAINWRIGHT CO.
375